Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].

Saved in:
Bibliographic Details
Title: Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69].
Authors: Akagi EM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., de Sá Júnior PL; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Simons SM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Bellini MH; Institute of Energy and Nuclear Research, IPEN, São Paulo, Brazil., Barreto SA; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil., Chudzinski-Tavassi AM; Laboratory of Molecular Biology, Butantan Institute, Avenue Vital Brazil, 1500, CEP 05503-900, São Paulo, SP, Brazil. Electronic address: ana.chudzinski@butantan.gov.br.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2019 Oct; Vol. 118, pp. 109108. Date of Electronic Publication: 2019 Jun 22.
Publication Type: Published Erratum
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1950-6007
DOI:10.1016/j.biopha.2019.109108